Arthur Agnieszka, Gronthos Stan
Mesenchymal Stem Cell Laboratory, Faculty of Health and Medical Sciences, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.
Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
Front Cell Dev Biol. 2021 Feb 9;9:598612. doi: 10.3389/fcell.2021.598612. eCollection 2021.
Skeletal integrity is maintained through the tightly regulated bone remodeling process that occurs continuously throughout postnatal life to replace old bone and to repair skeletal damage. This is maintained primarily through complex interactions between bone resorbing osteoclasts and bone forming osteoblasts. Other elements within the bone microenvironment, including stromal, osteogenic, hematopoietic, endothelial and neural cells, also contribute to maintaining skeletal integrity. Disruption of the dynamic interactions between these diverse cellular systems can lead to poor bone health and an increased susceptibility to skeletal diseases including osteopenia, osteoporosis, osteoarthritis, osteomalacia, and major fractures. Recent reports have implicated a direct role for the Eph tyrosine kinase receptors and their ephrin ligands during bone development, homeostasis and skeletal repair. These membrane-bound molecules mediate contact-dependent signaling through both the Eph receptors, termed , and through the ephrin ligands, referred to as . This review will focus on Eph/ ephrin cross-talk as mediators of hematopoietic and stromal cell communication, and how these interactions contribute to blood/ bone marrow function and skeletal integrity during normal steady state or pathological conditions.
骨骼完整性通过严格调控的骨重塑过程得以维持,该过程在出生后的整个生命过程中持续发生,以替换旧骨并修复骨骼损伤。这主要通过骨吸收破骨细胞与骨形成成骨细胞之间的复杂相互作用来维持。骨微环境中的其他成分,包括基质细胞、成骨细胞、造血细胞、内皮细胞和神经细胞,也有助于维持骨骼完整性。这些不同细胞系统之间动态相互作用的破坏可导致骨骼健康不佳,并增加患骨骼疾病的易感性,包括骨质减少、骨质疏松症、骨关节炎、骨软化症和严重骨折。最近的报告表明,Eph酪氨酸激酶受体及其 Ephrin配体在骨骼发育、稳态和骨骼修复过程中起直接作用。这些膜结合分子通过 Eph受体(称为 )和 Ephrin配体(称为 )介导接触依赖性信号传导。本综述将重点关注 Eph/Ephrin 相互作用作为造血细胞和基质细胞通讯的介质,以及这些相互作用在正常稳态或病理条件下如何促进血液/骨髓功能和骨骼完整性。
Front Cell Dev Biol. 2021-2-9
Int J Hematol. 2016-2
Clin Calcium. 2012-11
Adv Exp Med Biol. 2010
Front Immunol. 2019-7-4
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018-4-28
Cell Adh Migr. 2014
J Microbiol Biotechnol. 2025-2-13
Endocrinology. 2020-12-1
Calcif Tissue Int. 2020-12
Int J Mol Sci. 2020-8-6
Pharmaceuticals (Basel). 2020-6-30
Mol Biol Rep. 2020-7
Adv Cancer Res. 2020-6-12
Evid Based Complement Alternat Med. 2020-5-17
Expert Opin Investig Drugs. 2020-6